Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

PASG

Passage Bio (PASG)

Passage Bio Inc

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:PASG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
11/10/2020	7:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc
11/10/2020	7:00AM	GlobeNewswire Inc.	Passage Bio Reports Third Quarter 2020 Financial Results and Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
11/09/2020	7:00AM	GlobeNewswire Inc.	Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness...	NASDAQ:PASG	Passage Bio Inc
11/04/2020	7:00AM	GlobeNewswire Inc.	Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020	NASDAQ:PASG	Passage Bio Inc
10/28/2020	7:00AM	GlobeNewswire Inc.	Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease	NASDAQ:PASG	Passage Bio Inc
10/26/2020	7:00AM	GlobeNewswire Inc.	Passage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis	NASDAQ:PASG	Passage Bio Inc
10/13/2020	4:30PM	GlobeNewswire Inc.	Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal...	NASDAQ:PASG	Passage Bio Inc
10/06/2020	7:00AM	GlobeNewswire Inc.	Passage Bio to Participate in 2020 Virtual Cell & Gene Meeting on the Mesa	NASDAQ:PASG	Passage Bio Inc
09/25/2020	7:00AM	GlobeNewswire Inc.	Passage Bio to Participate in Upcoming October Investor Conferences	NASDAQ:PASG	Passage Bio Inc
09/17/2020	7:00AM	GlobeNewswire Inc.	Passage Bio Announces Publication of Preclinical Gene Therapy Study Data from Frontotemporal Dementia Program	NASDAQ:PASG	Passage Bio Inc
09/09/2020	7:02AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc
09/03/2020	8:00AM	GlobeNewswire Inc.	Passage Bio to Participate in Citi’s 15th Annual BioPharma Virtual Conference	NASDAQ:PASG	Passage Bio Inc
08/13/2020	8:03AM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PASG	Passage Bio Inc
08/13/2020	7:00AM	GlobeNewswire Inc.	Passage Bio Reports Second Quarter 2020 Financial Results and Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
08/07/2020	4:01PM	GlobeNewswire Inc.	Passage Bio to Report Second Quarter 2020 Financial Results on August 13, 2020	NASDAQ:PASG	Passage Bio Inc
06/26/2020	8:00AM	GlobeNewswire Inc.	Passage Bio Added to Russell 2000 Index	NASDAQ:PASG	Passage Bio Inc
06/10/2020	10:14AM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:PASG	Passage Bio Inc
06/04/2020	8:00AM	GlobeNewswire Inc.	Passage Bio to Present at Goldman Sachs 41st Annual Global Healthcare Conference	NASDAQ:PASG	Passage Bio Inc
05/21/2020	8:00AM	GlobeNewswire Inc.	Passage Bio Receives Rare Pediatric Disease Designation for PBGM01 for Patients with GM1 Gangliosidosis	NASDAQ:PASG	Passage Bio Inc
05/12/2020	5:00PM	GlobeNewswire Inc.	Passage Bio Announces Presentation of Data from Animal Models of Krabbe Disease at the American Society of Gene & Cell Therap...	NASDAQ:PASG	Passage Bio Inc
05/11/2020	4:08PM	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:PASG	Passage Bio Inc
05/11/2020	7:31AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc
05/11/2020	7:00AM	GlobeNewswire Inc.	Passage Bio Reports First Quarter 2020 Financial Results and Recent Business Highlights	NASDAQ:PASG	Passage Bio Inc
05/07/2020	8:01AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc
05/07/2020	7:30AM	GlobeNewswire Inc.	Passage Bio Announces Expansion of Gene Therapy Collaboration with University of Pennsylvania	NASDAQ:PASG	Passage Bio Inc
05/04/2020	8:00AM	GlobeNewswire Inc.	Passage Bio to Report First Quarter 2020 Financial Results on May 11, 2020	NASDAQ:PASG	Passage Bio Inc
04/21/2020	8:00AM	GlobeNewswire Inc.	FDA Grants Passage Bio Orphan Drug Designation for PBGM01 for Treatment of Infantile GM1 Gangliosidosis	NASDAQ:PASG	Passage Bio Inc
04/14/2020	6:04AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc
04/08/2020	8:00AM	GlobeNewswire Inc.	Passage Bio to Present at 19th Annual Needham Healthcare Conference	NASDAQ:PASG	Passage Bio Inc
04/03/2020	6:09AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:PASG	Passage Bio Inc

Showing the most relevant articles for your search:NASDAQ:PASG

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Maxeon Solar Technologies

Moon Equity (PK)

Hannover House (PK)

Golden Triangle Ventures (PK)

Decentral Life (PK)

Lightwave Logic

Cann American (CE)

Therapeutic Solutions (PK)

Intergrated Cannabis Sol... (PK)

Delayed Upgrade Clock